8-KMaterial AgreementsShareholder MattersExhibits & Filings

CASEYS GENERAL STORES INC 8-K Report, Material Agreement (Apr 16, 2010)

Filed April 16, 2010For Securities:CASY

Summary

Casey's General Stores, Inc. (CASY) announced on April 16, 2010, the adoption of a shareholder rights plan, commonly known as a "poison pill." This plan involves issuing one "right" for every share of common stock outstanding, entitling holders to purchase a fraction of a share of Series A Serial Preferred Stock at a specified price if triggered. The primary purpose of this move is to protect shareholders from coercive or inadequate takeover bids by giving the board time and leverage to negotiate. The rights will become exercisable if an individual or group acquires beneficial ownership of 15% or more of the company's outstanding common stock, or if the board designates a date following the commencement of a tender offer that could lead to such an acquisition. Upon activation, the rights provide for a "flip-in" provision, allowing holders (excluding the acquirer) to purchase discounted preferred stock, thereby diluting the acquirer's stake. A "flip-over" provision is also in place for mergers or asset sales, enabling rights holders to buy shares in the acquiring entity at a discount. The plan has an expiration date of April 15, 2011, and the board retains the right to redeem the rights before they become exercisable.

Key Highlights

  • 1Casey's General Stores adopted a shareholder rights plan (a "poison pill") effective April 16, 2010.
  • 2The plan involves issuing one 'right' per share of common stock, exercisable under specific takeover-related triggers.
  • 3Rights become exercisable if a person or group acquires 15% or more of the company's outstanding common stock, or upon board designation related to a tender offer.
  • 4The 'flip-in' provision allows rights holders (excluding the acquirer) to purchase discounted preferred stock if a 15% threshold is met.
  • 5The 'flip-over' provision protects shareholders in case of a merger or sale of substantially all assets to an acquirer.
  • 6The rights expire on April 15, 2011, unless redeemed earlier by the company's Board of Directors.
  • 7The Board of Directors retains the ability to redeem the rights at a nominal price of $0.001 per right before they become exercisable.

Frequently Asked Questions

The primary purpose of the shareholder rights plan, or 'poison pill,' is to protect the company and its shareholders from coercive or unfair takeover tactics. It is designed to give the Board of Directors time and leverage to evaluate any unsolicited takeover proposals and to negotiate for the best interests of shareholders, rather than allowing a hostile bidder to gain control through a rapid accumulation of shares.

The rights become exercisable upon the earlier of (1) a person or group acquiring beneficial ownership of 15% or more of the company's outstanding common stock, or (2) the Board of Directors designating a date following the commencement of a tender or exchange offer that could result in such an acquisition. Once exercisable, the 'flip-in' provision allows rights holders (excluding the acquirer) to purchase shares of the company's preferred stock at a substantial discount, effectively diluting the acquirer's stake and making the acquisition more expensive.

No, currently the rights are not exercisable and do not represent any shareholder rights, including voting rights or the right to receive dividends. They are essentially contingent rights that will only become active if the specified triggering events occur. Until then, they are attached to the common stock and transferable only with it.

Yes, the Board of Directors has the right to redeem all of the outstanding rights at any time prior to the date they become exercisable (the 'Distribution Date') for a nominal redemption price of $0.001 per right. The plan also has a set expiration date of April 15, 2011, after which the rights will expire if not previously redeemed or exercised.